2-(2,4-Dihydroxy-benzylcarbamoyl)-8-hydroxy-quinoline-7-carboxylic acid

ID: ALA81714

PubChem CID: 491467

Max Phase: Preclinical

Molecular Formula: C18H14N2O6

Molecular Weight: 354.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccc(O)cc1O)c1ccc2ccc(C(=O)O)c(O)c2n1

Standard InChI:  InChI=1S/C18H14N2O6/c21-11-4-1-10(14(22)7-11)8-19-17(24)13-6-3-9-2-5-12(18(25)26)16(23)15(9)20-13/h1-7,21-23H,8H2,(H,19,24)(H,25,26)

Standard InChI Key:  XCUIQBHAIMNBMZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    2.7971   -4.4474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5031   -4.0241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4852   -3.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7613   -2.8028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0539   -3.2355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0753   -4.0580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6428   -3.2538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6440   -4.0812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9292   -4.4940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9310   -2.8412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2157   -3.2502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2149   -4.0770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4997   -4.4879    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7847   -4.0732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7894   -3.2433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5053   -2.8361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0687   -4.4829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3600   -4.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0667   -4.0788    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3607   -5.3182    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9273   -5.3190    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6441   -4.0677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0655   -5.3079    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3601   -4.4773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3291   -2.8416    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1905   -2.7722    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  1  0
  1  2  2  0
 13 14  2  0
  3  4  2  0
 14 15  1  0
  7  8  2  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
  8  9  1  0
  9 12  2  0
  4  5  1  0
 18 19  1  0
 18 20  2  0
  8 18  1  0
 11 10  2  0
  9 21  1  0
 10  7  1  0
 17 22  1  0
  2  3  1  0
 17 23  2  0
  5  6  2  0
 22 24  1  0
 24  6  1  0
 11 12  1  0
  5 25  1  0
  6  1  1  0
  3 26  1  0
M  END

Associated Targets(Human)

CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3A Tclin Glycogen synthase kinase-3 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1/cyclin B1 (1887 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem CDK1/Cyclin A (118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1A1 Tchem Casein kinase I alpha (2581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK2 Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 2 (2095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CLK1 Tchem Dual specificty protein kinase CLK1 (2189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 integrase (9041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dyrk1a Dual-specificity tyrosine-phosphorylation regulated kinase 1A (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 354.32Molecular Weight (Monoisotopic): 354.0852AlogP: 1.98#Rotatable Bonds: 4
Polar Surface Area: 139.98Molecular Species: ACIDHBA: 6HBD: 5
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 3.36CX Basic pKa: 0.02CX LogP: 2.71CX LogD: -0.71
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.48Np Likeness Score: -0.31

References

1. Bénard C, Zouhiri F, Normand-Bayle M, Danet M, Desmaële D, Leh H, Mouscadet JF, Mbemba G, Thomas CM, Bonnenfant S, Le Bret M, d'Angelo J..  (2004)  Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity.,  14  (10): [PMID:15109635] [10.1016/j.bmcl.2004.03.005]
2. Sliman F, Blairvacq M, Durieu E, Meijer L, Rodrigo J, Desmaële D..  (2010)  Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase.,  20  (9): [PMID:20363627] [10.1016/j.bmcl.2010.03.061]

Source